- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
J Hepatol. 2019 Sep 6. pii: S0168-8278(19)30517-3. doi: 10.1016/j.jhep.2019.08.024. [Epub ahead of print]
TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Wang H1, Luo H1, Wan X1, Fu X2, Mao Q1, Xiang X1, Zhou Y1, He W1, Zhang J1, Guo Y1, Tan W3, Deng G4.
Author information
1
Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
2
Institute of Immunology, Third Military Medical University (Army Medical University), Chongqing 400038, China.
3
Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China. Electronic address: [email protected].
4
Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China. Electronic address: [email protected].
Abstract
BACKGROUND & AIMS:
The role of Hepatitis B virus (HBV)-specific CD4 T cells in chronic HBV infection patients is not clear.
METHODS:
Through intracellular IFN-γ and TNF-α staining, HBV-specific CD4 T cells were analyzed in 68 chronic HBV infection patients with alanine aminotransferase (ALT) < 2×upper limit of normal (ULN) and 28 hepatitis B flare patients. HBV-specific HLA-DRB1*0803/HLA-DRB1*1202-restricted CD4 T-cell epitopes were identified.
RESULTS:
TNF-α producing cells were the dominant population in patients' HBV-specific CD4 T cells. In patients with ALT < 2×ULN, both the frequency and the dominance of HBV-specific IFN-γ producing CD4 T cells increased sequentially in patients with elevated levels of viral clearance: HBeAg positive, HBeAg negative, and HBsAg negative. In hepatitis B flare patients, the frequency of HBV core-specific TNF-α producing CD4 T cells was positively correlated with patients' ALT and total bilirubin level, and the frequency of those cells changed in parallel with the severity of liver damage. Patients with HBeAg/HBsAg loss after flare showed higher frequency and dominance of HBV-specific IFN-γ producing CD4 T cells, compared to patients without HBeAg/HBsAg loss. Both the frequency and the dominance of HBV S-specific IFN-γ producing CD4 T cells were positively correlated with the decrease of HBsAg during flare. A differentiation process from TNF-α producing cell to IFN-γ producing cell in HBV-specific CD4 T cells was observed during flare. Eight and 9 HBV-derived peptides/pairs were identified as HLA-DRB1*0803 restricted epitopes and HLA-DRB1*1202 restricted epitopes, respectively.
CONCLUSIONS:
HBV-specific TNF-α producing CD4 T cells is associated with liver damage, while HBV-specific IFN-γ producing CD4 T cells is associated with viral clearance in chronic HBV infection patients.
LAY SUMMARY:
TNF-α producing cells are the dominant population of HBV-specific CD4 T cells in chronic HBV infection patients, and this population might contribute to the aggravation of liver damage in hepatitis B flare patients. HBV-specific IFN-γ producing CD4 T cells are associated with HBV viral clearance. Differentiation from HBV-specific TNF-α producing CD4 T cells into HBV-specific IFN-γ producing CD4 T cells might favor HBV viral clearance.
Copyright © 2019. Published by Elsevier B.V.
KEYWORDS:
CD4 T cells; Hepatitis B virus; epitope; liver damage; viral clearance
PMID:
31499130
DOI:
10.1016/j.jhep.2019.08.024 |
|